Neoadjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Borderline Resectable Esophageal Squamous Cell Carcinoma

J Gastrointest Surg. 2023 Dec;27(12):3040-3042. doi: 10.1007/s11605-023-05876-6. Epub 2023 Nov 2.

Authors

Hisahiro Hosogi¹, Shinya Yoshida², Masazumi Sakaguchi^{2

3}, Seiichiro Kanaya²

Affiliations

¹ Department of Surgery, Japanese Red Cross Osaka Hospital, 5-30 Fudegasakicho, Tennoji Ward, Osaka, 543-8555, Japan. hisahoso@kuhp.kyoto-u.ac.jp.
² Department of Surgery, Japanese Red Cross Osaka Hospital, 5-30 Fudegasakicho, Tennoji Ward, Osaka, 543-8555, Japan.
³ Department of Surgery, Kyoto City Hospital, Kyoto, Japan.

PMID: 37919516
DOI: 10.1007/s11605-023-05876-6

No abstract available

Keywords: Carcinoma, squamous cell; Esophageal neoplasms; Minimally invasive surgical procedures; Neoadjuvant therapy.

MeSH terms

Carcinoma, Squamous Cell* / pathology
Carcinoma, Squamous Cell* / therapy
Chemoradiotherapy
Esophageal Neoplasms* / pathology
Esophageal Squamous Cell Carcinoma* / surgery
Esophagectomy
Humans
Minimally Invasive Surgical Procedures
Neoadjuvant Therapy
Retrospective Studies